Association Between KRAS Variant Status and Outcomes With First-line Immune Checkpoint Inhibitor–Based Therapy in Patients With Advanced Non–Small-Cell Lung Cancer

This cohort study examines the association of KRAS status with outcomes following immune checkpoint inhibition monotherapy vs chemoimmunotherapy.

Shranjeno v:
Bibliografske podrobnosti
izdano v:JAMA Oncol
Main Authors: Sun, Lova, Hsu, Miles, Cohen, Roger B., Langer, Corey J., Mamtani, Ronac, Aggarwal, Charu
Format: Artigo
Jezik:Inglês
Izdano: American Medical Association 2021
Teme:
Research Letter
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC8050787/
https://ncbi.nlm.nih.gov/pubmed/33856403
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2021.0546
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki